Addressing the risk of bacterial contamination in platelets: a hospital economic perspective.

about

Residual risk of bacterial contamination: what are the options?Bacterial contamination of platelets for transfusion: strategies for prevention

P2860

Q49860144-ACAF1036-9E08-4EDD-8333-B85787F6C2CB Q58110468-17BDC9B3-0679-44F6-A25D-4B34818A14F4

P2860

Addressing the risk of bacterial contamination in platelets: a hospital economic perspective.

Item

http://www.wikidata.org/entity/Q38157873

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Addressing the risk of bacteri ...... hospital economic perspective.

@en

type

Item

label

Addressing the risk of bacteri ...... hospital economic perspective.

@en

prefLabel

Addressing the risk of bacteri ...... hospital economic perspective.

@en

P1476

Addressing the risk of bacteri ...... hospital economic perspective.

@en

P2093

Al Dobson

http://www.w3.org/2001/XMLSchema#string

Audrey El-Gamil

http://www.w3.org/2001/XMLSchema#string

Dorothy Chen

http://www.w3.org/2001/XMLSchema#string

Jessica L Jacobson

http://www.w3.org/2001/XMLSchema#string

Justin W Li

http://www.w3.org/2001/XMLSchema#string

Mark E Brecher

http://www.w3.org/2001/XMLSchema#string

Paul D Mintz

http://www.w3.org/2001/XMLSchema#string

Sarah K Harm

http://www.w3.org/2001/XMLSchema#string

P2860

Dose of prophylactic platelet transfusions and prevention of hemorrhage

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.

Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system.

Cost implications of implementation of pathogen-inactivated platelets

The introduction of 7-day platelets: a university hospital experience.

Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies.

The cost of blood transfusion in Western Europe as estimated from six studies.

Activity-based costs of plasma transfusions in medical and surgical inpatients at a US hospital.

Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance.

P31

scholarly article

P356

10.1111/TRF.14216

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28703862

http://www.w3.org/2001/XMLSchema#string

Addressing the risk of bacterial contamination in platelets: a hospital economic perspective.

about

P2860

P2860

Addressing the risk of bacterial contamination in platelets: a hospital economic perspective.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698